Fol-aCD3

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameFol-aCD3

Drug Alias Nameanti-CD3/folate conjugate T cell engager (Ambrx)anti-CD3/anti-FOLR-1 Amberstatin-conjugated T-cell engager (Ambrx)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsFolate receptor alpha modulators

TargetsFolate receptor alphaT cell surface glycoprotein CD3

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmbrx Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmbrx Inc

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A